Cantor Fitzgerald Keeps $40 PT on TG Therapeutics (TGTX), 'Label Looks Clean & Slightly Better Than Expectations'
Tweet Send to a Friend
Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating and $40.00 price target on TG Therapeutics (NASDAQ: TGTX)The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
